Novo Nordisk is a Danish multinational pharmaceutical company specialized in diabetes care. However, it also earned recognition for its battle to defeat obesity, haemophilia, growth disorders and other serious chronic disease. The diabetes care range consists of new-generation insulin, modern insulin, human insulin and well as glugacon-like Peptide 1, namely Victoza.